Mather Group’s Repligen RGEN Stock Holding History

Mather Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$187K	Hold	975	–	–	﹤0.01%	810
2026 Q2	$133K	Hold	975	–	–	﹤0.01%	864
2026 Q1	$115K	Buy	+975	New	+$136K	﹤0.01%	863
2025 Q4	–	Sell	-979	Closed	-$131K	–	1426
2025 Q3	$131K	Buy	+979	New	+$119K	﹤0.01%	717
2025 Q2	–	Sell	-987	Closed	-$126K	–	1468
2025 Q1	$126K	Hold	987	–	–	﹤0.01%	702
2024 Q4	$142K	Hold	987	–	–	﹤0.01%	664
2024 Q3	$147K	Sell	987 -40	-4%	-$5.74K	﹤0.01%	658
2024 Q2	$189K	Buy	1,027 +985	+2,345%	+$154K	﹤0.01%	630
2024 Q1	$7.55K	Buy	+42	New	+$8K	﹤0.01%	1272
2023 Q3	–	Sell	-975	Closed	-$138K	–	609
2023 Q2	$138K	Buy	+975	New	+$156K	﹤0.01%	559

Other funds holding RGEN

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Covea Finance Paris, France $3.07B AUM 27.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $809M AUM 17.64% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Mather Group's RGEN Position: Q3 2026 in Review

Mather Group held its Repligen (RGEN) position steady in Q3 2026 at 975 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Mather Group first reported a position in RGEN in Q2 2023 and has held it in 10 quarters since. The position peaked at $189K in Q2 2024. 77 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

Mather Group held 975 shares of Repligen worth $187K as of Q3 2026.
Mather Group left its Repligen share count unchanged in Q3 2026.
Repligen made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #810 holding.
Mather Group first reported a position in Repligen in Q2 2023 and has held it in 10 quarters since.
Mather Group's Repligen position peaked at $189K in Q2 2024.
77 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.